Arca
Skip to content
Tools
Tools

MicroTrend System

Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase. 510(k) K212425, from Exostat Medical, Inc. (Prior Lake, MN). Product code CCK, class 2.

As of Nov 18, 2026, K212425 is an FDA 510(k) held by Exostat Medical, Inc., substantially equivalent on Nov 7, 2024 after 1,191 days, with no recalls tied to it in FDA's recall database.

  • Review time: 1,191 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The MicroTrend is indicated for monitoring oral mucosal PCO2 in adult patients at risk of hemodynamic instability as an adjunct to other standard hemodynamic monitored parameters. This single-use device is indicated for use by qualified medical personnel to assess a patient's peripheral circulation status.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other CCK clearances

The newest 510(k)s for the same product code; their median review was 224 days; see every CCK device

Record

Type
Traditional
Received
Aug 4, 2021
Review panel
Anesthesiology
Regulation
21 CFR 868.1400

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.